Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Díaz San Segundo, Fayna ^a,c   Rodríguez Calvo, Teresa ^a   de Avila, Ana ^b   Sevilla, Noemí ^a,b  

^a Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria   (Spain)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^c PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IMMUNE DEFICIENCY; IN VITRO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; SWINE; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY; ACUTE DISEASE; ANIMAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MONOCYTE; PHYSIOLOGY; SWINE DISEASE; T LYMPHOCYTE; VIROLOGY; VIRUS REPLICATION;

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; SUIDAE; SUS;

ACUTE DISEASE; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; IMMUNE TOLERANCE; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MONOCYTES; SWINE; SWINE DISEASES; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 66249139921     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005659     Document Type: Article

References (59)

1. Orange JS, Fassett MS, Koopman LA, Boyson JE, Strominger JL (2002) Viral evasion of natural killer cells. Nat Immunol 3: 1006-1012.
2. Benedict CA, Norris PS, Ware CF (2002) To kill or be killed: viral evasion of apoptosis. Nat Immunol 3: 1013-1018.
3. Yewdell JW, Hill AB (2002) Viral interference with antigen presentation. Nat Immunol 3: 1019-1025.
4. Rouse BT, Horohov DW (1986) Immunosuppression in viral infections. Rev Infect Dis 8: 850-873.
5. Knight SC, Patterson S (1997) Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology. Annu Rev Immunol 15: 593-615.
6. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan MC, Liu YJ, et al. (1997) Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 186: 813-823.
7. Andrews DM, Andoniou CE, Granucci F, Ricciardi-Castagnoli P, Degli-Esposti MA (2001) Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol 2: 1077-1084.
8. Sevilla N, Kunz S, Holz A, Lewicki H, Homann D, et al. (2000) Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J Exp Med 192: 1249-1260.
9. Kruse M, Rosorius O, Kratzer F, Stelz G, Kuhnt C, et al. (2000) Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J Virol 74: 7127-7136.
10. Ho LJ, Wang JJ, Shaio MF, Kao CL, Chang DM, et al. (2001) Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol 166: 1499-1506.
11. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, et al. (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767-811.
12. Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9: 271-296.
13. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987-995.
14. Fujii S, Liu K, Smith C, Bonito AJ, Steinman RM (2004) The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 199: 1607-1618.
15. Munz C, Steinman RM, Fujii S (2005) Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med 202: 203-207.
16. Weigel BJ, Nath N, Taylor PA, Panoskaltsis-Mortari A, Chen W, et al. (2002) Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses. Blood 100: 4169-4176.
17. Ejrnaes M, von Herrath MG, Christen U (2006) Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies. Clin Dev Immunol 13: 337-347.
18. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, et al. (2006) Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12: 1301-1309.
19. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11: 165-190.
20. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, et al. (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22: 929-979.
21. Balabanian K, Foussat A, Bouchet-Delbos L, Couderc J, Krzysiek R, et al. (2002) Interleukin-10 modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite effects on stromal cell-derived factor-1 and Blymphocyte chemoattractant. Blood 99: 427-436.
22. Grubman MJ, Baxt B (2004) Foot-and-mouth disease. Clin Microbiol Rev 17: 465-493.
23. Rueckert RR, Wimmer E (1984) Systematic nomenclature of picornavirus proteins. J Virol 50: 957-959.
24. Sobrino F, Saiz M, Jimenez-Clavero MA, Nunez JI, Rosas MF, et al. (2001) Foot-and-mouth disease virus: a long known virus, but a current threat. Vet Res 32: 1-30.
25. Collen T, Baron J, Childerstone A, Corteyn A, Doel TR, et al. (1998) Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: the polymerase (P3Dpol) as an immunodominant T-cell immunogen. Virus Res 56: 125-133.
26. Collen T, Pullen L, Doel TR (1989) T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. J Gen Virol 70 (Pt 2): 395-403.
27. van Lierop MJ, van Maanen K, Meloen RH, Rutten VP, de Jong MA, et al. (1992) Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle. Immunology 75: 406-413.
28. Glass EJ, Millar P (1994) Induction of effective cross-reactive immunity by FMDV peptides is critically dependent upon specific MHC-peptide-T cell interactions. Immunology 82: 1-8.
29. Diaz-San Segundo F, Salguero FJ, de Avila A, de Marco MM, Sanchez-Martin MA, et al. (2006) Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. J Virol 80: 2369-2379.
30. Bautista EM, Ferman GS, Golde WT (2003) Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV). Vet Immunol Immunopathol 92: 61-73.
31. Guzylack-Piriou L, Bergamin F, Gerber M, McCullough KC, Summerfield A (2006) Plasmacytoid dendritic cell activation by foot-and-mouth disease virus requires immune complexes. Eur J Immunol 36: 1674-1683.
32. Harwood LJ, Gerber H, Sobrino F, Summerfield A, McCullough KC (2008) Dendritic cell internalization of foot-and-mouth disease virus: influence of heparan sulfate binding on virus uptake and induction of the immune response. J Virol 82: 6379-6394.
33. Reis e Sousa C (2006) Dendritic cells in a mature age. Nat Rev Immunol 6: 476-483.
34. Taylor A, Verhagen J, Blaser K, Akdis M, Akdis CA (2006) Mechanisms of immune suppression by interleukin-10 and transforming growth factor-β: the role of T regulatory cells. Immunology 117: 433-442.
35. Bautista EM, Ferman GS, Gregg D, Brum MC, Grubman MJ, et al. (2005) Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus. J Virol 79: 4838-4847.
36. Ostrowski M, Vermeulen M, Zabal O, Geffner JR, Sadir AM, et al. (2005) Impairment of thymus-dependent responses by murine dendritic cells infected with foot-and-mouth disease virus. J Immunol 175: 3971-3979.
37. Oldstone MB (1989) Viruses can cause disease in the absence of morphological evidence of cell injury: implication for uncovering new diseases in the future. J Infect Dis 159: 384-389.
38. Oldstone MB (2002) Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr Top Microbiol Immunol 263: 83-117.
39. de la Torre JC, Oldstone MB (1996) Anatomy of viral persistence: mechanisms of persistence and associated disease. Adv Virus Res 46: 311-343.
40. Sevilla N, McGavern DB, Teng C, Kunz S, Oldstone MBA (2004) Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J Clin Invest 113: 737-745.
41. Grubman MJ, Moraes MP, Diaz-San Segundo F, Pena L, de los Santos T (2008) Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen. FEMS Immunol Med Microbiol 53: 8-17.
42. Pierre P, Turley SJ, Gatti E, Hull M, Meltzer J, et al. (1997) Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388: 787-792.
43. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A (1997) Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388: 782-787.
44. Stumptner-Cuvelette P, Morchoisne S, Dugast M, Le Gall S, Raposo G, et al. (2001) HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci U S A 98: 12144-12149.
45. Cebulla CM, Miller DM, Zhang Y, Rahill BM, Zimmerman P, et al. (2002) Human cytomegalovirus disrupts constitutive MHC class II expression. J Immunol 169: 167-176.
46. Brady MT, MacDonald AJ, Rowan AG, Mills KH (2003) Hepatitis C virus nonstructural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol 33: 3448-3457.
47. Marín-Serrano E, Rodríguez-Ramos C, Diaz F, Martín-Herrera L, Girón-González JA (2006) Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin. J Viral Hepat 13: 230-234.
48. Carbonneil C, Donkova-Petrini V, Aouba A, Weiss L (2004) Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses induced by dendritic cells generated in the presence of IFN-alpha. J Immunol 172: 7832-7840.
49. Granelli-Piperno A, Golebiowska A, Trumpfheller C, Siegal FP, Steinman RM (2004) HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc Natl Acad Sci U S A 101: 7669-7674.
50. Ji J, Sahu GK, Braciale VL, Cloyd MW (2005) HIV-1 induces IL-10 production in human monocytes via a CD4-independent pathway. Int Immunol 17: 729-736.
51. Groux H, Bigler M, de Vries JE, Roncarolo MG (1996) Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 184: 19-29.
52. Ostrowski M, Vermeulen M, Zabal O, Zamorano PI, Sadir AM, et al. (2007) The early protective thymus-independent antibody response to foot-and-mouth disease virus is mediated by splenic CD9+ B lymphocytes. J Virol 81: 9357-9367.
53. Montes CL, Acosta-Rodríguez EV, Mucci J, Zuniga EI, Campetella O, et al. (2006) A Trypanosoma cruzi antigen signals CD11b+ cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibodysecreting cells. Eur J Immunol 36: 6.
54. Recher M, Lang KS, Hunziker L, Freigang S, Eschli B, et al. (2004) Deliberate removal of T cell help improves virus-neutralizing antibody production. Nat Immunol 5: 934-942.
55. Sobrino F, Davila M, Ortin J, Domingo E (1983) Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 128: 310-318.
56. de la Torre JC, Martinez-Salas E, Diez J, Villaverde A, Gebauer F, et al. (1988) Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture. J Virol 62: 2050-2058.
57. Sierra S, Davila M, Lowenstein PR, Domingo E (2000) Response of foot-andmouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J Virol 74: 8316-8323.
58. Garcia-Arriaza J, Manrubia SC, Toja M, Domingo E, Escarmis C (2004) Evolutionary transition toward defective RNAs that are infectious by complementation. J Virol 78: 11678-11685.
59. Gonzalez-Lopez C, Arias A, Pariente N, Gomez-Mariano G, Domingo E (2004) Pre-extinction viral RNA can interfere with infectivity. J Virol 78: 3319-3324.